Gentamicin release from biodegradable poly-l-lactide based composites for novel intramedullary nails

Materials Science and Engineering C

Volumn 45, Issue , 2014, Pages 15-20

  Morawska Chochół, Anna ^a   Domalik Pyzik, Patrycja ^a   Chłopek, Jan ^a   Szaraniec, Barbara ^a   Sterna, Jacek ^b   Rzewuska, Magdalena ^b   Boguń, Maciej ^c   Kucharski, Rafael ^d,e   Mielczarek, Przemysław ^a  

^a AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^c LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^d Vita Longa Sp z oo   (Poland)

^e IEE Group   (Germany)

Author keywords

Antibacterial activity; Composites; Degradable materials; Gentamicin release; Intramedullary nails; Poly(lactic acid)

Indexed keywords

ANTIBIOTICS; COMPOSITE MATERIALS; CONTROLLED DRUG DELIVERY; MAGNESIUM ALLOYS; REINFORCED PLASTICS; SULFUR COMPOUNDS; TARGETED DRUG DELIVERY;

ANTI-BACTERIAL ACTIVITY; BIOACTIVE PARTICLES; GENTAMICIN RELEASE; GENTAMICIN SULFATES; INTRAMEDULLARY NAILS; POLY LACTIC ACID; STRONG DEPENDENCES; TRICALCIUM PHOSPHATES;

NAILS;

ALLOY; ANTIBIOTICS; CARBON; COMPOSITES; MAGNESIUM; PROBLEM SOLVING; WIRE;

EID: 84907523663     PISSN: 09284931     EISSN: 18730191     Source Type: Journal    
DOI: 10.1016/j.msec.2014.08.059     Document Type: Article

References (37)

1. A. Trampuz, A. Gilomen, and U. Fluckiger Treatment outcome of infections associated with internal fixation devices: results from a 5-year retrospective study (1999-2003) 45th ICAAC, American Society for Microbiology, December 16-19, 2005, Washington, DC 2005
2. A. Trampuz, and W. Zimmerli Diagnosis and treatment of infections associated with fracture-fixation devices Inj. Int. J. Care Injured 37 2006 S59 S66
3. R.O. Darouiche Treatment of infections associated with surgical implants N. Engl. J. Med. 350 14 2004 1422 1429
4. J. Ciampolini, and K.G. Harding Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often? Postgrad. Med. J. 76 898 2000 479 483
5. M. Lucke, B. Wildemann, S. Sadoni, C. Surke, R. Schiller, and A. Stemberger Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in rat model Bone 36 2005 770 778
6. D. Neut, O.S. Kluin, J. Thompson, H.C. Mei, and H.J. Busscher Gentamicin release from commercially-available gentamicin-loaded PMMA bone cements in a prosthesis-related interfacial gap model and their antibacterial efficacy BMC Musculoskelet. Disord. 11 2010 258
7. G.H. Walenkamp Gentamicin PMMA beads and other local antibiotic carriers in two-stage revision of total knee infection: a review J. Chemother. 1 1 2001 66 72
8. H.P. Stallmann, C. Faber, A.L.J.J. Bronckers, A.V.N. Amerongen, and P.I.J.M. Wuisman In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile BMC Musculoskelet. Disord. 7 2006 18
9. Y. Yamashita, A. Uchida, T. Yamakawa, Y. Shinto, N. Araki, and K. Kato Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic Int. Orthop. 22 4 1998 247 251
10. T. Wu, Q. Zhang, W. Ren, X. Yi, Z. Zhou, and X. Peng Controlled release of gentamicin from gelatin/genipin reinforced beta-tricalcium phosphate scaffold for the treatment of osteomyelitis J. Mater. Chem. B 26 1 2013 3304 3313
11. L.D. Silverman, L. Lukashova, O.T. Herman, J.M. Lane, and A.L. Boskey Release of gentamicin from a tricalcium phosphate bone implant J. Orthop. Res. 25 2007 23 29
12. M. Teller, U. Gopp, H.G. Neumann, and K.D. Kuhn Release of gentamicin from bone regenerative materials: an in vitro study J. Biomed. Mater. Res. B Appl. Biomater. 81B 2007 23 29
13. A.J. Domb, N. Kumar, T. Sheskin, A. Bentolila, J. Slager, and D. Teomim Biodegradable polymers as drug carrier systems S. Dumitriu, Polymeric Biomaterials 2nd ed. 2002 Marcel Dekker Inc. New York
14. I. Gürsel, F. Korkusuz, F. Türesin, N.G. Alaeddingolu, and V. Hasirci In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis Biomaterials 22 1 2001 73 80
15. E.R. Balmayor, E.T. Baran, H.S. Azevedo, and R.L. Reis Injectable biodegradable starch/chitosan delivery system for the sustained release of gentamicin to treat bone infections Carbohydr. Polym. 87 1 2012 32 39
16. M.Y. Krasko, J. Golenser, A. Nyska, M. Nyska, Y.S. Brin, and A.J. Domb Gentamicin extended release from an injectable polymeric implant J. Control. Release 117 2007 90 96
17. Y.S. Brin, J. Golenser, B. Mizrahi, G. Maoz, A.J. Domb, and S. Peddada Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin J. Control. Release 131 2 2008 121 127
18. E. Sánchez, M. Baro, I. Soriano, A. Perera, and C. Évora In vivo-in vitro study of biodegradable and osteointegrable gentamicin bone implants Eur. J. Pharm. Biopharm. 52 2001 151 158
19. M. Baro, E. Sánchez, A. Delgado, A. Perera, and C. Évora In vitro-in vivo characterization of gentamicin bone implants J. Control. Release 83 2002 353 364
20. V. Alt, A. Bitschnau, A. Sewing, S. Wenisch, and R. Schnettler Gentamicin-hydroxyapatite and gentamicin-RGD-hydroxyapatite coating for cementless joint prostheses: a histomorphometrical and histological study in rats J. Bone Joint Surg. (Br.) 91-B 2009 303
21. M. Lucke, G. Schmidmaier, S. Sadoni, B. Wildemann, R. Schiller, N.P. Haas, and M. Raschke Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats Bone 32 5 2003 521 531
22. G.A. Zych, and J.J. Hutson Diagnosis and management of infection after tibial intramedullary nailing Clin. Orthop. Relat. Res. 315 1995 153 162
23. C.E. Chen, J.Y. Ko, J.W. Wang, and C.J. Wang Infection after intramedullary nailing of the femur J. Trauma 55 2 2003 338 344
24. M.H. Malik, P. Harwood, P. Diggle, and S.A. Khan Factors affecting rates of infection and nonunion in intramedullary nailing J. Bone Joint Surg. (Br.) 86 4 2004 556 560
25. R. Thonse, and J.D. Conway Antibiotic cement-coated nails for the treatment of infected nonunions and segmental bone defects J. Bone Joint Surg. Am. 90 2008 163 174
26. R. Thonse, and J. Conway Antibiotic cement-coated interlocking nail for the treatment of infected nonunions and segmental bone defects J. Orthop. Trauma 21 4 2007 258 268
27. A.K. Shyam, P.K. Sancheti, S.K. Patel, S. Rocha, C. Pradhan, and A. Patil Use of antibiotic cement-impregnated intramedullary nail in treatment of infected non-union of long bones Indian J. Orthop. 43 4 2009 396 402
28. © Synthes, Inc. Expert Tibial Nail PROtect Available at http://www.synthes.com/MediaBin/International%20DATA/036.001.264.pdf July 11, 2013
29. Synimed Synergie Ingénierie Médicale S.A.R.L. Synicem Clous Available: http://www.synimed.com/documents/pdf/Synicem%20Clous.pdf July 11, 2013
30. MEDGAL Openwork Nails Available: http://www.medgal.com.pl/en,ms-implants-for-inflammatory-condition-treatment-0-0-produkty.html July 11, 2013
31. A. Saikku-Bäckström, R.M. Tulamo, S.E. Räihä, T. Pohjonen, T. Toivonen, and P. Törmälä Intramedullary fixation of femoral cortical osteotomies with interlocked biodegradable self-reinforced poly-96l/4d-lactide (SR-PLA96) nails Biomaterials 25 2004 2669 2677
32. A. Morawska-Chochół, J. Chłopek, P. Domalik, and M. Boguń New composite materials based on polylactide matrix for intramedullary nails Eng. Biomater. 106-108 2011 99 104
33. A. Morawska-Chochół, J. Chłopek, P. Domalik-Pyzik, B. Szaraniec, and E. Grzys̈ka Magnesium alloy wires as reinforcement in composite intramedullary nails Biomed. Mater. Eng. 24 2014 1507 1515
34. United States Pharmacopeia 34 2012 Official Monographs/Gentamicin 2959 2960
35. W. Simchua, N.A. Narkkong, and Y. Baimark Silk fibroin nanospheres for controlled gentamicin sulfate delivery Res. J. Nanosci. Nanotechnol. 1 1 2011 34 41
36. P. Ramos, B. Pilawa, A. Krztoń, and B. Liszka Free radicals in the thermally sterilized aminoglycoside antibiotics. Research article Pharm. Anal. Acta 3 9 2012 1 13
37. D.A. Robinson, R.W. Griffith, D. Shechtman, R.B. Evans, and M.G. Conzemius In vitro antibacterial properties of magnesium metal against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus Acta Biomater. 6 2010 1869 1877